Journal
MARINE DRUGS
Volume 20, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/md20040244
Keywords
Demospongiae; bacteria; fungi; diverse bioactivities
Categories
Funding
- Antitumor Drugs and Vaccines from the Sea (ADViSE) project [PG/2018/0494374]
Ask authors/readers for more resources
Marine organisms, especially marine sponges belonging to the class of Demospongiae, have shown great potential as a source of bioactive compounds with various pharmacological activities, such as antiviral, anticancer, antifouling, antimicrobial, antiplasmodial, antifungal, and antioxidant properties. Compounds isolated from these sponges, like avarol from the marine sponge Disidea avara, have the potential to be developed into new drugs.
In the last decades, it has been demonstrated that marine organisms are a substantial source of bioactive compounds with possible biotechnological applications. Marine sponges, in particular those belonging to the class of Demospongiae, have been considered among the most interesting invertebrates for their biotechnological potential. In this review, particular attention is devoted to natural compounds/extracts isolated from Demospongiae and their associated microorganisms with important biological activities for pharmacological applications such as antiviral, anticancer, antifouling, antimicrobial, antiplasmodial, antifungal and antioxidant. The data here presented show that this class of sponges is an exciting source of compounds, which are worth developing into new drugs, such as avarol, a hydroquinone isolated from the marine sponge Disidea avara, which is used as an antitumor, antimicrobial and antiviral drug.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available